Jesus M. Ontoria

1.0k citations

26 papers · 796 indexed · h-index 18

Co-authors: Michael Rowley Philip Jones Carsten Schultz‐Fademrecht Federica Ferrigno Rita Scarpelli Maria Cecilia Palumbi Carlo Toniatti Sergio Altamura
Topics: Hepatitis C virus research (7 papers)Protein Degradation and Inhibitors (5 papers)Peptidase Inhibition and Analysis (5 papers)
Cited by: Hepatology Oncology Organic Chemistry
Journals: Journal of Medicinal Chemistry Tetrahedron Letters Bioorganic & Medicinal Chemistry
Partner nations: Italy United States Switzerland

In The Last Decade

Jesus M. Ontoria

26 papers receiving 757 citations

Peers

Countries citing papers authored by Jesus M. Ontoria

Since Specialization

Citations

This map shows the geographic impact of Jesus M. Ontoria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesus M. Ontoria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesus M. Ontoria more than expected).

Fields of papers citing papers by Jesus M. Ontoria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesus M. Ontoria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesus M. Ontoria. The network helps show where Jesus M. Ontoria may publish in the future.

Co-authorship network of co-authors of Jesus M. Ontoria

This figure shows the co-authorship network connecting the top 25 collaborators of Jesus M. Ontoria. A scholar is included among the top collaborators of Jesus M. Ontoria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesus M. Ontoria. Jesus M. Ontoria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Direct-to-biology platform: From synthesis to biological evaluation of SHP2 allosteric inhibitors 2024 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Federica Ferrigno,Monica Bisbocci,Cristina Alli,Jesus M. Ontoria,Alessia Petrocchi,Carlo Toniatti,Esther Torrente	1
2	SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease 2022 ·Bioorganic & Medicinal Chemistry ·Stefania Colarusso,Federica Ferrigno,(unknown),(unknown),Immacolata Conte,(unknown),Elisa Beghetto,Antonino Missineo,Jérôme Amaudrut,Alberto Bresciani,Giacomo Paonessa,Licia Tomei,Christian Montalbetti,Elisabetta Bianchi,Carlo Toniatti,Jesus M. Ontoria	6
3	Optimization of 2-(1H-imidazo-2-yl)piperazines series of Trypanosoma brucei growth inhibitors as potential treatment for the second stage of HAT 2020 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Federica Ferrigno,(unknown),(unknown),(unknown),Valentina Nardi,(unknown),Rita Graziani,Nadia Gennari,Maria Vittoria Orsale,(unknown),Giacomo Paonessa,Vincenzo Summa,Steven J. Harper,Jesus M. Ontoria	1
4	Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro 2018 ·Bioorganic & Medicinal Chemistry Letters ·Federica Ferrigno,(unknown),Savina Malancona,(unknown),Giacomo Paonessa,Rita Graziani,Alberto Bresciani,Nadia Gennari,Annalise Di Marco,Marcel Kaiser,Vincenzo Summa,Steven J. Harper,Jesus M. Ontoria	5
5	Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides 2018 ·ACS Medicinal Chemistry Letters ·Alberto Bresciani,Jesus M. Ontoria,(unknown),Antonella Cellucci,(unknown),Annalise Di Marco,Federica Ferrigno,(unknown),Savina Malancona,Edith Monteagudo,Emanuela Nizi,Paola Pace,(unknown),(unknown),Maria Veneziano,Vincenzo Summa,Steven J. Harper	26
6	N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides as highly potent smoothened antagonists 2011 ·Bioorganic & Medicinal Chemistry Letters ·Ester Muraglia,Jesus M. Ontoria,Danila Branca,(unknown),Alberto Bresciani,Massimiliano Fonsi,Claudio Giuliano,(unknown),Edith Monteagudo,Maria Cecilia Palumbi,(unknown),Michael Rowley,Christian Steinkühler,Philip Jones	17
7	Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: Structure-based design and synthesis of new templates 2010 ·Bioorganic & Medicinal Chemistry ·Savina Malancona,Monica Donghi,Marco Ferrara,José Ignacio Martı́n Hernando,(unknown),Silvia Pesci,Jesus M. Ontoria,Uwe Koch,Michael Rowley,Vincenzo Summa	25
8	Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Jesus M. Ontoria,Jonathan C. Cruz,Michael Rowley,Carsten Schultz‐Fademrecht,Christian Steinkühler,Philip Jones	26
9	Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Federica Orvieto,Danila Branca,(unknown),Philip Jones,Uwe Koch,Jesus M. Ontoria,Maria Cecilia Palumbi,Michael Rowley,Carlo Toniatti,Ester Muraglia	48
10	Discovery and SAR of novel, potent and selective hexahydrobenzonaphthyridinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1) 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Monica Bisbocci,Raffaele Ingenito,Jesus M. Ontoria,Michael Rowley,Carsten Schultz‐Fademrecht,Carlo Toniatti,Philip Jones	12
11	Optimization of Thienopyrrole‐Based Finger‐Loop Inhibitors of the Hepatitis C Virus NS5B Polymerase 2009 ·ChemMedChem ·José Ignacio Martı́n Hernando,Jesus M. Ontoria,Savina Malancona,(unknown),(unknown),Fabio Bonelli,Uwe Koch,Stefania Di Marco,Stefania Colarusso,(unknown),Nadia Gennari,(unknown),Marı́a del Rosario Rico Ferreira,Jörg Habermann,Michael Rowley,Frank Narjes	22
12	Synthesis and biological evaluation of substituted 2-phenyl-2H-indazole-7-carboxamides as potent poly(ADP-ribose) polymerase (PARP) inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Rita Scarpelli,(unknown),Mauro Cerretani,Federica Ferrigno,Jesus M. Ontoria,Michael Rowley,Carsten Schultz‐Fademrecht,Carlo Toniatti,Philip Jones	20
13	Identification of Novel, Selective, and Stable Inhibitors of Class II Histone Deacetylases. Validation Studies of the Inhibition of the Enzymatic Activity of HDAC4 by Small Molecules as a Novel Approach for Cancer Therapy 2009 ·Journal of Medicinal Chemistry ·Jesus M. Ontoria,Sergio Altamura,Annalise Di Marco,Federica Ferrigno,Ralph Laufer,Ester Muraglia,Maria Cecilia Palumbi,Michael Rowley,Rita Scarpelli,Carsten Schultz‐Fademrecht,Sergio Serafini,Christian Steinkühler,Philip Jones	42
14	Studies of the metabolic stability in cells of 5-(trifluoroacetyl)thiophene-2-carboxamides and identification of more stable class II histone deacetylase (HDAC) inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Rita Scarpelli,Annalise Di Marco,Federica Ferrigno,Ralph Laufer,(unknown),Ester Muraglia,Jesus M. Ontoria,Michael Rowley,Sergio Serafini,Christian Steinkühler,Philip Jones	17
15	2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Philip Jones,Matthew J. Bottomley,Andrea Carfı́,(unknown),Federica Ferrigno,Paola Lo Surdo,Jesus M. Ontoria,Michael Rowley,Rita Scarpelli,Carsten Schultz‐Fademrecht,Christian Steinkühler	52
16	Identification of thieno[3,2-b]pyrroles as allosteric inhibitors of hepatitis C virus NS5B polymerase 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jesus M. Ontoria,José Ignacio Martı́n Hernando,Savina Malancona,(unknown),Ian Stansfield,Immacolata Conte,(unknown),Jörg Habermann,(unknown),Marcello Di Filippo,Uwe Koch,Michael Rowley,Frank Narjes	33
17	Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part I: Amides and Ureas 2005 ·Letters in Drug Design & Discovery ·Benedetta Crescenzi,(unknown),Jesus M. Ontoria,Antonio Marchetti,Emanuela Nizi,Victor G. Matassa,Cristina Gardelli	6
18	SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease 2004 ·Bioorganic & Medicinal Chemistry Letters ·Savina Malancona,Stefania Colarusso,Jesus M. Ontoria,(unknown),(unknown),Ian Stansfield,Ralph Laufer,Annalise Di Marco,Marina Taliani,(unknown),(unknown),Victor G. Matassa,Frank Narjes	20
19	Capped dipeptide phenethylamide inhibitors of the HCV NS3 protease 2004 ·Bioorganic & Medicinal Chemistry Letters ·Emanuela Nizi,Uwe Koch,Jesus M. Ontoria,(unknown),Frank Narjes,Savina Malancona,Victor G. Matassa,Cristina Gardelli	13
20	Synthesis of Two Novel Cyclic Biphenyl Ether Analogs of an Inhibitor of HCV NS3 Protease 1999 ·Synlett ·(unknown),Jesus M. Ontoria,Victor G. Matassa	20

About Jesus M. Ontoria

Jesus M. Ontoria is a scholar working on Hepatology, Pharmacy and Oncology, having authored 26 papers that have together received 796 indexed citations. Recurring topics across this work include Hepatitis C virus research (7 papers), Protein Degradation and Inhibitors (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Hepatology (100 citations), Oncology (304 citations) and Organic Chemistry (287 citations). Jesus M. Ontoria has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Michael Rowley, Philip Jones, Carsten Schultz‐Fademrecht, Federica Ferrigno, Rita Scarpelli, Maria Cecilia Palumbi, Carlo Toniatti, Sergio Altamura, Christian Steinkühler and Silvia Pesci. Their work appears in journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact